1 An ensemble classification of exudates in color fundus images using an evolutionary algorithm based optimal features selection.

2 Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

3 clinical applications of spectral domain optical coherence tomography in retinal diseases

4 [Study of lutein and zeaxanthin content in the diet with the assessment of the relationship between the level of alimentary intake of non-vitamin carotenoids and the density of the macular region of the retina at a young age].

5 A two genes - for - one gene interaction between Leptosphaeria maculans Brassica napus.

6 Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes.

7 Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

8 Targeting modifiable risk factors in age-related macular degeneration in optometric practice in Sweden

9 Retinal angiographic alteration in diabetic macular edema after dexamethasone implantation: a case report

10 Targeting modifiable risk factors in age-related macular degeneration in optometric practice in Sweden

11 Targeting modifiable risk factors in age-related macular degeneration in optometric practice in Sweden

12 Evaluation of the Effect of Repeated Intravitreal Bevacizumab Injections on the Macular Microvasculature of a Diabetic Patient Using Optical Coherence Tomography Angiography

13 Macular Rash, Thrombocytopenia, and Hyperbilirubinemia in a Preterm Infant

14 Retinal angiographic alteration in diabetic macular edema after dexamethasone implantation: a case report

15 Characteristics of Diabetic Capillary Nonperfusion in Macular and Extramacular White Spots on Optical Coherence Tomography Angiography.

16 Diabetic Nonperfused Areas in Macular and Extramacular Regions on Wide-Field Optical Coherence Tomography Angiography.

17 Expression of vascular infarction-related molecules after anti-vascular endothelium growth factor treatment for diabetic macular edema.

18 Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.

19 Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema

20 Aqueous Humor Cytokines and Long-Term Response to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema

21 Outer retinal alterations associated with visual outcomes in Best vitelliform macular dystrophy.

22 Congenital hepatic fibrosis and coexistent retinal macular degeneration: A case report.

23 Interactome Mapping Guided by Tissue-Specific Phosphorylation in Age-Related Macular Degeneration.

24 Longitudinal Macular Structure-Function Relationships in Glaucoma and Their Sources of Variability

25 Computer-based detection of age-related macular degeneration and glaucoma using retinal images and clinical data

26 Systematic ultrastructural comparison of swept-source and full-depth spectral domain optical coherence tomography imaging of diabetic macular oedema.

27 Green synthesis of Ni@Fe3O4 and CuO nanoparticles using Euphorbia maculata extract as photocatalysts for the degradation of organic pollutants under UV-irradiation

28 Polarization Variability in Age-related Macular Degeneration.

29 Single and joint effects of chronic exposure to chlorpyrifos and glyphosate based pesticides on structural biomarkers in Cnesterodon decemmaculatus

30 Dynamics of ovarian maturation during the reproductive cycle of Metynnis maculatus, a reservoir invasive fish species (Teleostei: Characiformes)

31 Relationship between HTRA1 polymorphism and genetic susceptibility of wet age-related macular degeneration in Han population

32 Intravitreal injection of perfluoropropane for the treatment of vitreomacular traction

33 Influence of mydriasis on optical coherence tomography angiography imaging in patients with age-related macular degeneration.

34 Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration.

35 A management strategy for the long-term conservation of the Endangered sand-dune lizard Liolaemus multimaculatus in the Pampean coastal dunes of Argentina

36 Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration?

37 Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial.

38 New Mechanism for the Sex Differences in Salt-Sensitive Hypertension: The Role of Macula Densa NOS1β-Mediated Tubuloglomerular Feedback.

39 Knockout of Na+-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration

40 Macula densa SGLT1-NOS1-tubuloglomerular feedback pathway, a new mechanism for glomerular hyperfiltration during hyperglycemia

41 StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.

42 Near-Infrared Reflectance Imaging for Quantification of Atrophy associated with Age-related Macular Degeneration.

43 Large idiopathic macular hole surgery: remodeling of outer retinal layers after traditional internal limiting membrane peeling or inverted flap technique.

44 Analysis of the Arg345Trp disease-associated allele of the EFEMP1 gene in individuals with early onset drusen or familial age-related macular degeneration.

45 Predicting optical coherence tomography-derived diabetic macular edema grades from fundus photographs using deep learning

46 Deep learning for detecting retinal detachment and discerning macular status using ultra-widefield fundus images

47 [A differentiated approach to analysis of retinal fluid and assessment of its effect on anti-VEGF therapy of neovascular age-related macular degeneration].

48 Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration?

49 Autologous internal limiting membrane transplant for recurrent idiopathic macular holes.

50 Short-term changes in posterior vitreous cortex following intravitreal ocriplasmin for symptomatic vitreomacular traction syndrome: a prospective study.

51 Traumatic Macular Hole

52 Removal of Retained Subfoveal Perfluorocarbon Liquid Through a Therapeutic Macular Hole

53 Pharmacologic vitreolysis for vitreomacular traction syndrome and macular hole: From clinical trials to clinical practice

54 Vitreous and macular hole: genesis and nemesis: A vitreous plug as reason for treatment failure

55 Morphology of the vitreoretinal interface in fellow eyes of patientswith full thickness macular holes

56 Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole

57 Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy

58 Influence of Macular Hole Width on Visual Acuity, Endotamponade and Closure Rate

59 Macular hole treated by the inverted internal limiting membrane flap technique: case report

60 Therapeutic Options in Vitreomacular Traction with or Without a Macular Hole

61 Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole: First clinical experiences

62 Traumatic macular hole with central retinal detachment and choroidal rupture with ora serrata dialysis

63 Smartphone-operated detonation of a firecracker resulting in a macular hole

64 Vitreomacular interface diseases: Vitreomacular adhesion, traction, epiretinal membrane, and macular hole

65 Functional and morphological correlations in macular hole surgery

66 Transconjunctival sutureless pars plana vitrectomy and brilliant peel (BP)-assisted ILM peeling in patients with macular holes

67 Study on the time course of macular pigment density measurement in patients with a macular hole - Clinical course and impact of surgery

68 23-gauge versus 20-gauge vitrectomy: Analysis of 110 consecutive cases undergoing epiretinal membrane peeling and macular hole repair

69 Is choroidal thickness of importance in idiopathic macular hole?

70 Pars Plana Vitrectomy for Idiopathic Macular Hole - Visual Improvement or Merely Surgical Stress?

71 Macular hole, optic neuropathy, keratoconjunctivitis sicca and bilateral cataract after high-voltage injury

72 Visual development of postoperative persistent macular holes with and without surgical revision

73 Comparison of ILM peeling with and without the use of indocyanine green. Functional results for idiopathic macular hole after pars plana vitrectom

74 Functional results after anatomically successful surgery for stage III/IV macular hole

75 Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration.

76 Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.

77 Retinal Spectral Domain Optical Coherence Tomography in Early Atrophic Age-Related Macular Degeneration (AMD) and a New Metric for Objective Evaluation of the Efficacy of Ocular Nutrition

78 Axial Length as a Factor Associated With Visual Outcome After Vitrectomy for Diabetic Macular Edema

79 Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography

80 Effects of Retinal Morphology on Contrast Sensitivity and Reading Ability in Neovascular Age-Related Macular Degeneration

81 Retinal-image quality and contrast-sensitivity function in age-related macular degeneration

82 Vitreous surgery for macular pucker

83 Function and Morphology of Macula before and after Removal of Idiopathic Epiretinal Membrane

84 Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration

85 Simple Estimation of Clinically Relevant Lesion Volumes Using Spectral Domain–Optical Coherence Tomography in Neovascular Age-Related Macular Degeneration

86 Effects of Retinal Morphology on Contrast Sensitivity and Reading Ability in Neovascular Age-Related Macular Degeneration

87 Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan

88 Prognostic factors in vitrectomy for epiretinal membranes of the macula

89 Changes in contrast sensitivity after surgery for macula-on rhegmatogenous retinal detachment

90 Macular Perfusion Impairment in Von Hippel-Lindau Disease Suggests a Generalized Retinal Vessel Alteration

91 Topographic Distribution of Contractile Protein in the Human Macular Microvasculature

92 Removal of epimacular membranes

93 Contrast Sensitivity Evaluation in Eyes Predisposed to Age-Related Macular Degeneration and Presenting Normal Visual Acuity

94 Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane

95 Prevention of age related macular degeneration

96 Imaging of macular diseases with optical coherence tomography

97 Glaucomatous Macular Vasculature: A Quantitative Analysis

98 Multifocal retinal contraction in macular pucker analyzed by combined optical coherence tomography/scanning laser ophthalmoscopy

99 Following the Status of Visual Cortex Over Time in Patients With Macular Degeneration Reveals Atrophy of Visually Deprived Brain Regions

100 The incidence of idiopathic preretinal macular gliosis

101 Contrast sensitivity evaluation in eyes predisposed to age-related macular degeneration and presenting normal visual acuity

Keyword Connections

Journals

Research Groups

Bibliographies